{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:17:42Z","timestamp":1773281862613,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.ophtha.2009.01.014","type":"journal-article","created":{"date-parts":[[2009,4,20]],"date-time":"2009-04-20T04:36:16Z","timestamp":1240202176000},"page":"1151-1157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Analysis of the Effect of Intravitreal Bevacizumab Injection on Diabetic Macular Edema after Cataract Surgery"],"prefix":"10.1016","volume":"116","author":[{"given":"Yoshihiro","family":"Takamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Akagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2009.01.014_bib1","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/S0161-6420(88)32991-X","article-title":"The incidence of visual loss in a diabetic population","volume":"95","author":"Moss","year":"1988","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.01.014_bib2","first-page":"1","article-title":"Pathophysiology of diabetic macular edema","volume":"39","author":"Joussen","year":"2007","journal-title":"Dev Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.01.014_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00055735-200302000-00007","article-title":"Managing cystoid macula edema after cataract surgery","volume":"14","author":"Nelson","year":"2003","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.01.014_bib4","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1001\/archopht.117.12.1600","article-title":"Results after lens extraction in patients with diabetic retinopathy: Early Treatment Diabetic Retinopathy Study report number 25","volume":"117","author":"Chew","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.01.014_bib5","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.ophtha.2006.08.053","article-title":"Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography","volume":"114","author":"Kim","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.01.014_bib6","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/archopht.1997.01100160595012","article-title":"A comparison of retinal morphology viewed by optical coherence tomography and by light microscopy","volume":"115","author":"Toth","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.01.014_bib7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0161-6420(98)93601-6","article-title":"Topography of diabetic macular edema with optical coherence tomography","volume":"105","author":"Hee","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.01.014_bib8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000083266","article-title":"Optical coherence tomographic assessment of diabetic macular edema: comparison with fluorescein angiographic and clinical findings","volume":"219","author":"Ozdek","year":"2005","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ophtha.2009.01.014_bib9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000088382","article-title":"Detection of early diabetic change with optical coherence tomography in type 2 diabetes mellitus patients without retinopathy","volume":"219","author":"Sugimoto","year":"2005","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ophtha.2009.01.014_bib10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3928\/1542-8877-20000501-04","article-title":"Optical coherence tomography for retinal thickness measurement in diabetic patients without clinically significant macular edema","volume":"31","author":"Schaudig","year":"2000","journal-title":"Ophthalmic Surg Lasers"},{"key":"10.1016\/j.ophtha.2009.01.014_bib11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/bjo.76.4.228","article-title":"The course of diabetic retinopathy following cataract surgery in eyes previously treated by laser photocoagulation","volume":"76","author":"Pollack","year":"1992","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.01.014_bib12","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1001\/archopht.1985.01050120030015","article-title":"Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1","volume":"103","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.01.014_bib13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archopht.125.4.469","article-title":"Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema","volume":"125","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.01.014_bib14","first-page":"557","article-title":"The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery","volume":"96","author":"Flach","year":"1998","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ophtha.2009.01.014_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0886-3350(02)01441-4","article-title":"Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema","volume":"29","author":"Conway","year":"2003","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.ophtha.2009.01.014_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/IAE.0b013e31802e3e5c","article-title":"Intraocular triamcinolone acetonide for pseudophakic cystoid macular edema: optical coherence tomography and multifocal electroretinography study","volume":"27","author":"Koutsandrea","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2009.01.014_bib17","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0002-9394(14)72159-2","article-title":"Pars plana vitrectomy for chronic pseudophakic cystoid macular edema","volume":"120","author":"Harbour","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.01.014_bib18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: basic science and clinical progress","volume":"25","author":"Ferrara","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ophtha.2009.01.014_bib19","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ophtha.2005.10.030","article-title":"Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macula edema","volume":"113","author":"Funatsu","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.01.014_bib20","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2009.01.014_bib21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer","volume":"3","author":"Ferrara","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ophtha.2009.01.014_bib22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2005.11.019","article-title":"Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.01.014_bib23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00006982-200603000-00005","article-title":"Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study","volume":"26","author":"Iturralde","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2009.01.014_bib24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ophtha.2006.12.028","article-title":"Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up","volume":"114","author":"Arevalo","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.01.014_bib25","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.ophtha.2007.05.062","article-title":"A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema","volume":"114","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.01.014_bib26","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/archopht.1993.01090060119035","article-title":"The Lens Opacities Classification System III","volume":"111","author":"Chylack","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.01.014_bib27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3928\/1542-8877-20000701-07","article-title":"Combined modified grid and panretinal photocoagulation for diffuse diabetic macular edema and proliferative diabetic retinopathy","volume":"31","author":"Lee","year":"2000","journal-title":"Opthalmic Surg Lasers"},{"issue":"suppl","key":"10.1016\/j.ophtha.2009.01.014_bib28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2337\/diab.32.2.S20","article-title":"Studies on the pathophysiology of diabetic retinopathy: the blood-retinal barrier in diabetes","volume":"32","author":"Cunha-Vaz","year":"1983","journal-title":"Diabetes"},{"key":"10.1016\/j.ophtha.2009.01.014_bib29","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0161-6420(81)80009-7","article-title":"Pseudophakic cystoid maculopathy: a study of 50 cases","volume":"88","author":"Stern","year":"1981","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.01.014_bib30","first-page":"2408","article-title":"VEGF-initiated blood-retinal barrier breakdown in early diabetes","volume":"42","author":"Qaum","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2009.01.014_bib31","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/bjo.2005.087403","article-title":"Diabetic cataract removal: postoperative progression of maculopathy\u2014growth factor and clinical analysis","volume":"90","author":"Patel","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.01.014_bib32","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00006982-200603000-00018","article-title":"Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema","volume":"26","author":"Mason","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2009.01.014_bib33","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.jcrs.2007.07.046","article-title":"Primary intravitreal bevacizumab for the management of pseudophakic cystoid macular edema: pilot study of the Pan-American Collaborative Retina Study Group","volume":"33","author":"Arevalo","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.ophtha.2009.01.014_bib34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jcrs.2007.08.021","article-title":"Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema","volume":"34","author":"Spitzer","year":"2008","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.ophtha.2009.01.014_bib35","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0886-3350(02)01319-6","article-title":"Factors affecting visual outcomes after small-incision phacoemulsification in diabetic patients","volume":"28","author":"Somaiya","year":"2002","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.ophtha.2009.01.014_bib36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ajo.2003.09.016","article-title":"The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macula edema","volume":"137","author":"Kang","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.01.014_bib37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archopht.121.1.57","article-title":"Intravitreal injection of triamcinolone for diffuse diabetic macular edema","volume":"121","author":"Jonas","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.01.014_bib38","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.ophtha.2004.05.025","article-title":"Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial","volume":"111","author":"Sutter","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.01.014_bib39","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ophtha.2003.05.037","article-title":"Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial","volume":"111","author":"Massin","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.01.014_bib40","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0161-6420(02)00975-2","article-title":"Intravitreal triamcinolone for refractory diabetic macular edema","volume":"109","author":"Martidis","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.01.014_bib41","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ajo.2007.12.031","article-title":"Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema","volume":"145","author":"Shimura","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.01.014_bib42","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.ophtha.2008.06.015","article-title":"A randomized trial comparing intravitreal triamcinolone acetonide and focal\/grid photocoagulation for diabetic macular edema","volume":"115","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.01.014_bib43","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.ophtha.2007.02.010","article-title":"Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study","volume":"114","year":"2007","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642009000414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642009000414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:58:01Z","timestamp":1758981481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642009000414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0161642009000414"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2009.01.014","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of the Effect of Intravitreal Bevacizumab Injection on Diabetic Macular Edema after Cataract Surgery","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2009.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}